Ravioli Trees and Tortellini Bushes: What Should Courts Expect from the Reasonable Consumer When it Comes to “Natural” Claims?

Posted on January 2014 by John E. Villafranco, Partner & Katie Bond, Associate Kelley Drye & Warren LLP

This issue of Policy Forum (Volume 4, Number 1, January 29, 2014) –Ravioli Trees and Tortellini Bushes: What Should Courts Expect from the Reasonable Consumer When it Comes to “Natural&...read more

Is It Time for Harmonized Cosmetics Standards? A Comparison of U.S. and E.U. Cosmetics Regulation

Posted on December 2013 by Kimberly K. Egan, Founder, Saltbox Consulting and Jennifer A. Fuerch, Attorney

In this Policy Forum, Egan and Fuerch provide a comparative analysis of the regulation of cosmetics in the United State and European Union.  The authors highlight increasing safety concerns wi...read more

Do Pending State Biosimilar Substitution Bills Violate State Constitutional Law Principles of Non-Delegation and Incorporation by Reference?

Posted on September 2013 by Neal Parker Section Head, Legal, Biologics Strategic Development, AbbVie

In this Policy Forum, Parker explains that since Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) in 2010, several state legislatures have introduced and some have enacte...read more

Is Caronia the Most Important FDA Related Judicial Decision of Our Generation?

Posted on August 2013 by Ralph Hall, Professor of Practice at the University of Minnesota Law School, Of Counsel at Faegre Baker Daniels and CEO of MR 3 Medical LLC

This issue of Policy Forum (Volume 3, Issue 14, August 29, 2013)—“Is Caronia the Most Important FDA Related Judicial Decision of Our Generation?” by Ralph Hall (Professor of Pract...read more

Out on a Limb: How Will the Prohibition of Biomedical Research Using Chimpanzees Harm Public Health?

Posted on March 2013 by Fern P. O’Brian, Partner, and Barbara A. Lum, Associate, Thompson Hine, LLP

In this issue of our Policy Forum (Volume 3, Number 5, March 13, 2013) – Out on a Limb: How Will the Prohibition of Biomedical Research Using Chimpanzees Harm Public Health? – examines ...read more

What Does the Second Circuit’s Recent Decision in United States v. Caronia Not Say?

Posted on February 2013 by Geoffrey R. Kaiser, Founder, Kaiser Law Firm, PLLC; Former Chief of Healthcare Fraud Prosecutions, United States Attorney’s Office for the Eastern District of New York

This issue of Policy Forum (Volume 3, Number 3, February 13, 2013) — "What Does the Second Circuit’s Recent Decision in United States v. Caronia Not Say?" — deconstructs the landm...read more

by Peter Barton Hutt This issue of the Policy Forum (Volume 2, Number 16, August 22, 2012), The Statutory Authority of FDA to Regulate Cosmetics: A Response to Thomas Cluderay and Jason Rano&...read more

Should Congress Expand FDA Authority Over Cosmetics and, if so, How?

Posted on April 2012 by Thomas Cluderay and Jason Rano

by Thomas Cluderay and Jason Rano FDLI's Policy Forum (Volume 2, Number 8, April 25, 2012) deals with a topic just discussed in the halls of Congress: Should Congress Expand FDA's Authority O...read more

James M. Solyst of ENVIRON International Corporation makes the argument that, at a time when federal budgets are precarious, the private sector must be prepared to continue to contribute to the sci...read more

read more